Introduction

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The story of a man called marty who is enrolled in a clinical trial for early onset outsimers. Marty's grandfather died from it in his late forties. He was one of 14 siblings, 12 of them had outsimers and had died by their early fifties. Would you flip the coin to find out? Or live your life never knowing, but always wondering?

Marty Reiswig is fit and healthy, but every two weeks he is injected with the experimental drug gantenerumab and has monthly MRI scans. He submits to this because a rare genetic mutation runs in his family that predisposes them to early-onset Alzheimer’s disease.

We spoke to him about his experience on the trial, and why he chose to continue trialling the drug even after formal clinical trials were discontinued.

Produced and narrated by Lorna Stewart.

More on this story:

News Feature: Could drugs prevent Alzheimer’s? These trials aim to find out

Resources for those affected by Alzheimer's:

Alzheimer's association

Alzheimers.gov

Alzheimer's society

Hosted on Acast. See acast.com/privacy for more information.